4//SEC Filing
Vong John 4
Accession 0001104659-23-119141
CIK 0001083446other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 4:30 PM ET
Size
17.7 KB
Accession
0001104659-23-119141
Insider Transaction Report
Form 4
Vong John
SVP-Chief Accounting Officer
Transactions
- Disposition to Issuer
Common Stock
2023-07-01−1,520→ 5,291 total - Disposition to Issuer
Common Stock
2023-07-01−1,520→ 6,811 total - Award
Common Stock
2023-05-16+760→ 7,571 total - Award
Common Stock
2023-05-16+760→ 8,331 total - Award
Common Stock
2023-05-16+1,520→ 5,291 total - Tax Payment
Common Stock
2023-07-11$32.07/sh−325$10,423→ 4,966 total - Disposition to Issuer
Common Stock
2023-05-16−4,164→ 3,771 total - Award
Common Stock
2023-05-16+1,520→ 6,811 total
Footnotes (7)
- [F1]Represents cancellation of all performance-based restricted stock awards granted on December 12, 2022.
- [F2]Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. The shares of restricted stock were scheduled to vest upon achievement of a pre-established performance goal on or before July 1, 2023. The applicable performance goal was not met, and the restricted shares were forfeited.
- [F3]Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. The shares of restricted stock were scheduled to vest upon achievement of a pre-established performance goal on or before July 1, 2023. The applicable performance goal was not met, and the restricted shares were forfeited.
- [F4]Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal on or before July 1, 2023, which performance goal was met.
- [F5]Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal.
- [F6]This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award that vested on July 11, 2023.
- [F7]Includes 4,349 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 2,829 shares, of which 942 shares vest on each of July 11, 2024 and July 11, 2025 and 945 shares vest on July 11, 2026; (ii) 760 shares, which vest in four equal annual installments beginning on November 30, 2023; and (iii) 760 shares, which vest upon achievement of certain pre-established performance goals.
Documents
Issuer
Apollo Medical Holdings, Inc.
CIK 0001083446
Entity typeother
Related Parties
1- filerCIK 0001572846
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 4:30 PM ET
- Size
- 17.7 KB